The Globe and Mail reports in its Tuesday edition that Credit Suisse analyst Andrew Kuske cut Enbridge ($50.76) to "neutral" from "outperform," citing the stock's recent outperformance against peer TransCanada ($46.65). The Globe's Darcy Keith writes in the Eye On Equities column that year-to-date, Enbridge has returned 9.5 per cent, versus 5 per cent for TransCanada. Mr. Kuske says, "Beyond that simple comparative, we believe ENB faces less economic sensitivity than TRP in a recovering economic environment, offers a lower dividend yield and more expensive price-to-earnings driven valuation." Mr. Kuske targets the shares at $52. Mr. Kuske says he is not advising investors to sell their shares of Enbridge. He says: "We believe Enbridge has an attractive and unique asset base capable of sustained growth. In our view, Enbridge may be viewed as a core holding, with one of North America's largest infrastructure footprints." The analyst consensus price target on Enbridge is $53.69. Credit Suisse raised its price target on TransCanada to $58 from $54 and maintained an "outperform" rating. RBC analyst Robert Kwan rated Enbridge "outperform" in the Eye column on March 6. The shares were then worth $48.79.